Company

Background

Articular Engineering, LLC is an Illinois based biotech company focused on the development of tissue engineered products designed to advance the current treatment options for articular cartilage and intervertebral disc disorders. Much of the product portfolio is based upon the patented “Alginate-Recovered-Chondrocyte” or “ARC” technology. The company was established in 1999 by a group of orthopedic surgeons and researchers affiliated with Rush-Presbyterian-St. Luke’s Medical Center in Chicago. Company principals are leaders in the fields of Orthopedic Surgery and Biochemistry. Offices and labs are located on the north side of Chicago, in Northbrook Illinois.

Vision

Combining the fields of engineering, biology, and medicine, Tissue Engineering holds an enormous potential to benefit patients and the economy by improving treatment options, providing jobs, and reducing the cost of medical care. Grown-to-order tissue may some day be used to repair complex tissues or even organs, and perhaps help to alleviate the need for donor organs. Although some of these advancements are decades away, in the not so distant future orthopedic surgeons will be able to repair damaged cartilage or arthritic joints using tissue-engineered products. AE’s objective is to become a leader in the field of orthopedic cell-based therapy.

©Copyright 2006 Articular Engineering All rights reserved